Mesenchymal stromal cells (donor-derived)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesenchymal stromal cells (donor-derived), covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs [Phase 2]